No Data
No Data
Olin Biology (688319.SH): received government subsidies of 5.005 million yuan.
On June 28th, GeLonghui reported that Olin Biotech (688319.SH) announced that its controlling subsidiary, Chengdu Xin Nuoming Biotechnology Co., Ltd., received a government subsidy of RMB 5,005,061.15 on June 28th, 2024, including government subsidies related to revenue of RMB 5,005,061.15 and government subsidies related to assets of 0 yuan.
Subdued Growth No Barrier To Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) With Shares Advancing 26%
Olin Bio (688319.SH) will distribute cash dividends for the 2023 fiscal year on June 25, with a dividend of 0.038 yuan per share.
Olin Biology (688319.SH) announced that the company will distribute the annual report for 2023 on June 25, 2024.
About 117 million restricted shares of Olin Biotech (688319.SH) will be listed and circulated from June 11
According to Zhitong Finance App News, Olin Biotech (688319.SH) announced that the restricted shares currently listed and circulated are restricted shares in the initial public offering. The limited sale period is 36 months from the date of listing of the company's shares. The number of shareholders involved is 3. The number of corresponding restricted shares is about 117 million shares, accounting for 28.85% of the company's total share capital up to now. The current limited sales period is about to expire, and it will be listed and distributed from June 11, 2024.
Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 11% Gain Last Week Benefited Both Retail Investors Who Own 42% as Well as Insiders
Olin Biotech (688319.SH) announced its 2023 annual results, with net profit of 17.56 million yuan, a year-on-year decrease of 33.94%
Olin Biotech (688319.SH) disclosed its 2023 annual report, and the company achieved revenue of 4 in 2023...
No Data